Safety and immunogenicity of the 23-valent pneumococcal polysaccharide vaccine at 12 months of age, following one, two, or three doses of the 7-valent pneumococcal conjugate vaccine in infancy

被引:28
作者
Russell, F. M. [1 ,7 ]
Licciardi, P. V. [2 ]
Balloch, A. [2 ]
Biaukula, V. [3 ]
Tikoduadua, L. [3 ]
Carapetis, J. R. [4 ]
Nelson, J. [4 ]
Jenney, A. W. J. [1 ]
Waqatakirewa, L. [3 ]
Colquhoun, S. [1 ]
Cheung, Y. B. [5 ,6 ]
Tang, M. L. K. [2 ]
Mulholland, E. K. [4 ,8 ]
机构
[1] Univ Melbourne, Ctr Int Child Hlth, Dept Paediat, Royal Childrens Hosp, Melbourne, Vic, Australia
[2] Royal Childrens Hosp, Murdoch Childrens Res Inst, Melbourne, Vic, Australia
[3] Minist Hlth, Suva, Fiji
[4] Charles Darwin Univ, Menzies Sch Hlth Res, Darwin, NT 0909, Australia
[5] Singapore Clin Res Inst, Singapore, Singapore
[6] Duke NUS Grad Med Sch, Singapore, Singapore
[7] Univ Melbourne, Ctr Int Child Hlth, Dept Paediat, Melbourne, Vic, Australia
[8] London Sch Hyg & Trop Med, London WC1, England
基金
英国医学研究理事会;
关键词
Pneumococcal; Polysaccharide; Booster; ACUTE OTITIS-MEDIA; STREPTOCOCCUS-PNEUMONIAE; NASOPHARYNGEAL CARRIAGE; CHILDREN; ANTIBODY; EFFICACY; DISEASE; IMMUNIZATION; INFECTIONS; REDUCTION;
D O I
10.1016/j.vaccine.2010.02.065
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Fijian infants aged 6 weeks were stratified by ethnicity and randomized to receive 0, 1, 2, or 3 PCV-7 doses with or without the 23-valent pneumococcal polysaccharide vaccine (PPV-23) at 12 months. Strong booster effects for all 7 PCV-7 serotypes were elicited, and for 4/7 serotypes these responses were highest in the single PCV-7 group. There were fourfold rises in GMC for all non-PCV-7 serotypes. By 17 months the PPV-23 group still had significantly higher GMC (each p < 0.001) for all serotypes. The PPV-23 was well tolerated and induced excellent responses for all serotypes which were greatest in the single PCV-7 group. (C) 2010 Elsevier Ltd. All rights reserved.
引用
收藏
页码:3086 / 3094
页数:9
相关论文
共 48 条
[1]   Streptococcus pneumonia capsular polysaccharide-diphtheria toxoid conjugate vaccine is immunogenic in early infancy and able to induce immunologic memory [J].
Åhman, H ;
Käyhty, H ;
Lehtonen, H ;
Leroy, O ;
Froeschle, J ;
Eskola, J .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1998, 17 (03) :211-216
[2]   Dose dependency of antibody response in infants and children to pneumococcal polysaccharides conjugated to tetanus toxoid [J].
Åhman, H ;
Käyhty, H ;
Vuorela, A ;
Leroy, O ;
Eskola, J .
VACCINE, 1999, 17 (20-21) :2726-2732
[3]   Avidity of IgG for Streptococcus pneumoniae type 6B and 23F polysaccharides in infants primed with pneumococcal conjugates and boosted with polysaccharide or conjugate vaccines [J].
Anttila, M ;
Eskola, J ;
Åhman, H ;
Käyhty, H .
JOURNAL OF INFECTIOUS DISEASES, 1998, 177 (06) :1614-1621
[4]   Differences in the avidity of antibodies evoked by four different pneumococcal conjugate vaccines in early childhood [J].
Anttila, M ;
Eskola, J ;
Åhman, H ;
Käyhty, H .
VACCINE, 1999, 17 (15-16) :1970-1977
[5]  
BALLOCH A, 2006, 5 INT S PNEUM PNEUM
[6]  
Black JE Steven., 2008, Vaccines, V4, P531, DOI [10.1016/B978-1-4160-3611-1.50027-1, DOI 10.1016/B978-1-4160-3611-1.50027-1]
[7]   A comparison of multiple regimens of pneumococcal polysaccharide-meningococcal outer membrane protein complex conjugate vaccine and pneumococcal polysaccharide vaccine in toddlers [J].
Blum, MD ;
Dagan, R ;
Mendelman, PM ;
Pinsk, V ;
Giordani, M ;
Li, S ;
Bohidar, N ;
McNeely, TB .
VACCINE, 2000, 18 (22) :2359-2367
[8]   Immunogenicity and reactogenicity of a pneumococcal conjugate vaccine administered combined with a Haemophilus influenzae type b conjugate vaccine in United Kingdom infants [J].
Choo, S ;
Seymour, L ;
Morris, R ;
Quataert, S ;
Lockhart, S ;
Cartwright, K ;
Finn, A .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2000, 19 (09) :854-862
[9]   EFFECTS OF PNEUMOCOCCAL VACCINATION ON TONSILLO-PHARYNGITIS AND UPPER RESPIRATORY-TRACT FLORA [J].
CHRISTENSEN, P ;
HOVELIUS, B ;
PRELLNER, K ;
ROSEN, C ;
CHRISTENSEN, KK ;
KURL, DN ;
LARSSON, L ;
STJERNQUISTDESATNIK, A ;
SCHALEN, C .
INTERNATIONAL ARCHIVES OF ALLERGY AND APPLIED IMMUNOLOGY, 1985, 78 (02) :161-166
[10]   Pneumococcal type 22F polysaccharide absorption improves the specificity of a pneumococcal-polysaccharide enzyme-linked immunosorbent assay [J].
Concepcion, NF ;
Frasch, CE .
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 2001, 8 (02) :266-272